Abstract
Background: Catastrophic antiphospholipid syndrome (APS) is defined as life threatening multiple organ thromboses developing simultaneously or over a short period. The survival rate of catastrophic APS is about 50%, but the long term outcome of patients who survive is unknown.
Objective: To determine the long term outcome of patients with catastrophic APS and provide further information on patients who survived.
Patients and methods: The clinical characteristics and outcomes of 130 patients with catastrophic APS have been reported previously. Six new cases were recently added to this series. Based on these publications, the authors who reported patients who had survived were contacted. Each author was asked (a) what treatment they gave their patients after the catastrophic APS; (b) if their patients had any further thrombosis.
Results: 63/136 (46%) patients died at the initial event. Of the remaining 73 patients, information was available for 58 (79%). Thirty eight (66%) patients did not develop further APS related events during an average follow up of 67.2 months. Eleven (19%) patients developed further APS related events but were still alive. No patients developed further catastrophic APS. Nine (16%) patients died: due to multiple organ failure (three patients); myelofibrosis (one); pneumonia (one); and APS related events (four).
Conclusion: Sixty six per cent of patients who survive an initial catastrophic APS event remained symptom free with anticoagulation during an average follow up of 67.2 months. Twenty six per cent of the survivors developed further APS related events and the mortality rate of these patients was about 25%.
Full Text
The Full Text of this article is available as a PDF (99.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asherson R. A. A "primary" antiphospholipid syndrome? J Rheumatol. 1988 Dec;15(12):1742–1746. [PubMed] [Google Scholar]
- Asherson R. A., Cervera R., Piette J. C., Font J., Lie J. T., Burcoglu A., Lim K., Muñoz-Rodríguez F. J., Levy R. A., Boué F. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998 May;77(3):195–207. doi: 10.1097/00005792-199805000-00005. [DOI] [PubMed] [Google Scholar]
- Asherson R. A., Cervera R., Piette J. C., Shoenfeld Y., Espinosa G., Petri M. A., Lim E., Lau T. C., Gurjal A., Jedryka-Góral A. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001 Nov;80(6):355–377. doi: 10.1097/00005792-200111000-00002. [DOI] [PubMed] [Google Scholar]
- Asherson R. A., Khamashta M. A., Ordi-Ros J., Derksen R. H., Machin S. J., Barquinero J., Outt H. H., Harris E. N., Vilardell-Torres M., Hughes G. R. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989 Nov;68(6):366–374. [PubMed] [Google Scholar]
- Asherson R. A. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992 Apr;19(4):508–512. [PubMed] [Google Scholar]
- Asherson Ronald A., Espinosa Gerard, Cervera Ricard, Font Josep, Reverter Joan Carles. Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment. J Clin Rheumatol. 2002 Jun;8(3):157–165. [PubMed] [Google Scholar]
- Erkan D., Yazici Y., Sobel R., Lockshin M. D. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol. 2000 Dec;27(12):2817–2821. [PubMed] [Google Scholar]
- Erkan Doruk, Leibowitz Evan, Berman Jessica, Lockshin Michael D. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol. 2002 Apr;29(4):843–849. [PubMed] [Google Scholar]
- Khamashta M. A., Cuadrado M. J., Mujic F., Taub N. A., Hunt B. J., Hughes G. R. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995 Apr 13;332(15):993–997. doi: 10.1056/NEJM199504133321504. [DOI] [PubMed] [Google Scholar]
- Krnic-Barrie S., O'Connor C. R., Looney S. W., Pierangeli S. S., Harris E. N. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Arch Intern Med. 1997 Oct 13;157(18):2101–2108. [PubMed] [Google Scholar]
- Muñoz-Rodriguez F. J., Font J., Cervera R., Reverter J. C., Tàssies D., Espinosa G., López-Soto A., Carmona F., Balasch J., Ordinas A. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum. 1999 Dec;29(3):182–190. doi: 10.1016/s0049-0172(99)80029-8. [DOI] [PubMed] [Google Scholar]
- Rosove M. H., Brewer P. M. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 1992 Aug 15;117(4):303–308. doi: 10.7326/0003-4819-117-4-303. [DOI] [PubMed] [Google Scholar]
- Wilson W. A., Gharavi A. E., Koike T., Lockshin M. D., Branch D. W., Piette J. C., Brey R., Derksen R., Harris E. N., Hughes G. R. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999 Jul;42(7):1309–1311. doi: 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]